Analysis of the immunosuppressive state in patients with malignant brain tumors
Analysis of the immunosuppressive state in patients with malignant brain tumors
批准号:
11671362
负责人:
NAGANUMA Hirofumi
金额:
$2.3万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Background : Malignant glioma cells secreted both thrombospondin-1 (TSP-1) and transforming growth factor-b (TGF-β) and the expression of both cytokines correlated with malignancy of gliomas. (Neuropathology 20 : 161, 2000) TSP-I has a potential to activate a latent form of TGF-β.Purpose : Experiments were performed to elucidate whether 1) TSP-1 secreted by malignant glioma cells participates in a latent TGF-β activaticn, and 2) a synthetic peptide which are found In TSP-1 moleoule and has a function of adhesion Can inhibit a motility of glioma cells. We established an ELISA for measurement of TSP-1 secretion by malignant glioma Cells.Results :1) Role of TSP-1 in latent TGF-β activation : Neutralizing anti-TSP-1 mouse monoclonal antibody or rabbit polyclonal antibody was added to culture medium of malignant glioma cells. The active form of TGF-β In the supernatants was measured by ELISA Addition of the antibodies resulted in a decrease of the active TGF-β in the supernatants in a dose-related manner. This Indicates that TSP-1 participates in the latent TGF-b activation. (Neurol Med Chir (Tokyo), in press)2) Inhibition of motility of glioma cells by a synthetic peptide : To examine the role of TSP-1 in motility of glioma cells, malignant glioma cells wae treated with a synthetic peptide which includes three adhesion sites in TSP-1 molecule. The motility of glioma cells was Inhibited by the peptide in a dose-related manner. The result agrees with the previous observation that transfection of antisense TSP-1 cDNA into glioma cells resulted in a decrease of motility of glioma cells. (Manuscript submitted)3) Measurement of TSP-1 in culture supernatants by ELISA : A sandwich ELISA using mouse anti-TSP-1 antibody and rabbit antibody was established Concentrations of TSP-1 in culture supernatants of 9 glioma cell lines were 43 - 2431 ng/1 x 10^6 cells/24 hours (643 ± 838 ; mean ± SD), while that of malignant melanoma (DFB) was 7.5 ng/1 x 10^6 cells/24 hours.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
佐々木厚: "Participation of thrombospondin-1 in the activation of latent transforming growth factor-β in malignant glioma cells"Neurol Med Chir (Tokyo). (in press).
Atsushi Sasaki:“血小板反应蛋白-1 参与恶性神经胶质瘤细胞中潜在转化生长因子-β 的激活”Neurol Med Chir(东京)(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Evaluation of immunotherapy using dendritic cells and tumor antigen peptide against patients with malignant gliomas
-
批准号:13671428
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.98万
-
财政年份:2001
-
负责人:NAGANUMA Hirofumi
-
依托单位:
Analysis of immunosuppressive states in patients with malignant glioma
-
批准号:09671414
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.98万
-
财政年份:1997
-
负责人:NAGANUMA Hirofumi
-
依托单位:
Analysis of TGF-beta receptors in malignant glioma cells
-
批准号:07671507
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1995
-
负责人:NAGANUMA Hirofumi
-
依托单位:
国内基金
海外基金
肿瘤恶病质中肿瘤外泌体Thrombospondin 2介导巨噬细胞代谢重编程的作用及机制研究
-
批准号:82303818
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:范萌
-
依托单位:
CD47和thrombospondin-1调节糖尿病肾病代谢性炎症的作用和机制
-
批准号:82330020
-
项目类别:重点项目
-
资助金额:220万元
-
批准年份:2023
-
负责人:侯凡凡
-
依托单位:
Thrombospondin-1抑制ADSCs构建组织工程化软骨骨化的相关研究
-
批准号:81401611
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:谢爱国
-
依托单位: